SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Remes-Troche J.M.
(Autor externo)

Obras con ISBN:0
Documentos en revistas:65
Colaboraciones en Tesis:0
Patentes:0
Obras con ISBN:No hay obras de este autor.
Documentos en revistas:
1.- The Fifth Mexican consensus on the diagnosis and treatment of Helicobacter pylori infectionV consenso mexicano sobre el diagnóstico y tratamiento de la infección por Helicobacter pylori (2026)
 
2.- Survey of Latin American gastroenterologists, specialists in disorders of gut-brain interaction, on the diagnosis and treatment of irritable bowel syndrome in clinical practiceEncuesta en gastroenterólogos latinoamericanos expertos en trastornos del eje intestino-cerebro sobre el diagnóstico y el tratamiento del síndrome de intestino irritable en la práctica clínica (2025)
 
3.- Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024; (2025)
 
4.- Clinical practice recommendations on the use of neuromodulators in gastroenterology: AMG (Asociación Mexicana de Gastroenterología) - AMNM (Asociación Mexicana de Neurogastroenterología y Motilidad) expert joint review; (2025)
 
5.- Changing Landscape of Liver Cirrhosis Etiologies (2025)
 
6.- Efficacy and safety of lubiprostone for the treatment of chronic idiopathic constipation: A phase 3, randomized, placebo-controlled study; (2024)
 
7.- Impact of COVID-19 on pre-existing liver disease; (2024)
 
8.- Good clinical practice recommendations for the diagnosis and treatment of gastroesophageal reflux disease. An expert review from the Asociación Mexicana de Gastroenterología; (2024)
 
9.- The Mexican consensus on fecal incontinence; (2023)
 
10.- Primer consenso centroamericano y del Caribe del smdrome de intestino irritable (2023)
 
11.- Global multi-stakeholder endorsement of the MAFLD definition (2022)
 
12.- Degree of agreement on the management of patients with gastroesophageal reflux disease. A study among specialists that are members of the Sociedad Latinoamericana de Neurogastroenterología (SLNG) (2022)
 
13.- Approach to the patient with cholestasis and jaundice syndrome. Joint AMH, AMG, and AMEG scientific position statement (2022)
 
14.- Body composition and phase angle by bioimpedance in patients with MAFLD (2022)
 
15.- Obesity Contributes to Inflammation in Patients with IBS via Complement Component 3 and C-Reactive Protein (2022)
 
16.- Normal values and regional differences in oesophageal impedance-pH metrics: A consensus analysis of impedance-pH studies from around the world (2021)
 
17.- The Mexican consensus on the detection and treatment of early gastric cancer (2020)
 
18.- Towards precision medicine: defining and characterizing adipose tissue dysfunction to identify early immunometabolic risk in symptom-free adults from the GEMM family study (2020)
 
19.- The importance of lactose intolerance in individuals with gastrointestinal symptoms (2020)
 
20.- Erratum to: The Mexican consensus on the diagnosis and treatment of diverticular disease of the colon? (Revista de Gastroenterología de México (2019) 84(2) (220?240), (S037509061930045X), (10.1016/j.rgmx.2019.01.002)) (2019)
 
21.- The Mexican consensus on non-cardiac chest pain (2019)
 
22.- Consensus on the prevention, diagnosis, and treatment of Clostridium difficile infection (2019)
 
23.- The Mexican consensus on the diagnosis and treatment of diverticular disease of the colon (2019)
 
24.- Rifaximina-alfa en el tratamiento de la enfermedad diverticular. Evidencia y conceptos actuales (2019)
 
25.- The Mexican consensus on chronic constipation (2018)
 
26.- The fourth Mexican consensus on Helicobacter pylori (2018)
 
27.- Deep multi-OMICs and multi-tissue characterization in a pre-and postprandial state in human volunteers: The GEMM family study research design (2018)
 
28.- Clinical guidelines on the diagnosis and treatment of celiac disease in Mexico (2018)
 
29.- How to improve the diagnosis of eosinophilic esophagitis: Experience from a case series in Mexico (2017)
 
30.- Mexican consensus on dyspepsia (2017)
 
31.- Diagnosis and treatment of gastroesophageal reflux disease: recommendations of the Asociación Mexicana de Gastroenterología (2016)
 
32.- Elevated circulating levels of IL-21 and IL-22 define a cytokine signature profile in type 2 autoimmune hepatitis patients (2016)
 
33.- Inter-observer agreement for diagnostic classification of esophageal motility disorders defined in high-resolution manometry (2015)
 
34.- Relief of night-time symptoms associated with gastroesophageal reflux disease following 4 weeks of treatment with pantoprazole magnesium: The mexican gastroesophageal reflux disease working group (2014)
 
35.- Microbiota, infecciones gastrointestinales, inflamación de bajo grado y antibioticoterapia en el síndrome de intestino irritable. Una revisión basada en evidencias (2014)
 
36.- Microbiota gastrointestinal y síndrome de intestino irritable. Respuesta a García-Mazcorro (2014)
 
37.- Mexican consensus on the diagnosis and management of hepatocellular carcinoma Abstract [Consenso mexicano de diagnóstico y manejo del carcinoma hepatocelular] (2014)
 
38.- Practical guideline of the Central American and Caribbean Association of Gastroenterology and Gastrointestinal Endoscopy for the management of gastroesophageal reflux disease (GERD) [Guía práctica de la asociación centroamericana y del ca (2014)
 
39.- Vectores polares como método para evaluar la eficacia de tratamientos para el síndrome de intestino irritable: Análisis con bromuro de pinaverio 100mg más simeticona 300mg po bid (2013)
 
40.- [The Mexican consensus on gastroesophageal reflux disease. Part I]. [Consenso Mexicano de enfermedad por relujo gastroesofágico. Parte I.] (2012)
 
41.- Receiving the baton [Cambio de estafeta] (2012)
 
42.- "Designing a tailored suit": Inhibitors of proton pump in gastroesophageal reflux disease (2012)
 
43.- ¿Si no hay ácido no hay pirosis? Nuevos mecanismos fisiopatológicos de la enfermedad por reflujo gastroesofágico (2011)
 
44.- Prevalence and characterization of the IBS subtypes according to the Rome III criteria in patients from a clinical, multicentric study. A report from the Mexican IBS Working Group [Prevalencia y caracterización de los subtipos de SII según (2010)
 
45.- Gastric capacity is related to body mass index in obese patients. A study using the water load test (2009)
 
46.- Liver transplantation for neurologic Wilson's Disease: Reflections on two cases within a Mexican cohort (2009)
 
47.- Early gastric cancer in Menetrier's disease (2009)
 
48.- Intraepithelial ?d+ lymphocytes: A comparative study between celiac disease, small intestinal bacterial overgrowth, and irritable bowel syndrome (2007)
 
49.- Drinking capacity and severity of dyspeptic symptoms during a water load test after Nissen fundoplication (2007)
 
50.- Crohn's disease of the esophagus. (2006)
 
51.- When should we be concerned about pancreatic necrosis? Analysis from a single institution in Mexico City (2006)
 
52.- Progressive dysphagia caused by isolated esophageal involvement of Crohn's disease [2] (2005)
 
53.- Maximum tolerated volume in drinking tests with water and a nutritional beverage for the diagnosis of functional dyspepsia (2005)
 
54.- Utility of rabeprazole as a diagnostic test in non-erosive gastroesophageal reflux disease [Utilidad del rabeprazol como prueba diagnóstica en la enfermedad por reflujo gastroesofágico no erosiva.] (2005)
 
55.- Hemoconcentration is a poor predictor of severity in acute pancreatitis (2005)
 
56.- Functional dyspepsia [Dispepsia funcional.] (2004)
 
57.- Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease [Medición exitosa del pH esofágico con la cápsula Bravo en pacientes con enfermedad por reflujo gastroesofágico.] (2004)
 
58.- Single pancreatic metastasis from a previously resected carcinoma of the cecum: A case report (2004)
 
59.- Diagnostic usefulness of the Carlsson-Dent questionnaire in gastroesophageal reflux disease (GERD) [Utilidad diagnóstica del cuestionario de Carlsson-Dent en la enfermedad por reflujo gastroesofágico (ERGE).] (2004)
 
60.- Perception of symptoms with minimal reductions of esophageal pH in patients with erosive and non-erosive GERD [Percepción de síntomas con descensos mínimos en el pH esofágico en pacientes con ERGE erosiva y no erosiva.] (2004)
 
61.- Response of thymectomy: Clinical and pathological characteristics among seronegative and seropositive myasthenia gravis patients (2004)
 
62.- Effect of ulcerative colitis in the bursting strength of colonic anastomoses in the rats (2003)
 
63.- Actual concepts of celiac disease physiopathogenesis [Conceptos actuales en la fisiopatología de la enfermedad celiaca] (2003)
 
64.- Thalamic and mesencephalic hemorrhages after multiple honeybee stings: A life-threatening apitherapy complication (2003)
 
65.- Recommendations for the reopening and activity resumption of the neurogastroenterology units in the face of the COVID-19 pandemic. Position of the Sociedad Latinoamericana de Neurogastroenterología ()
 
Colaboraciones en Tesis:No hay tesis de este autor.
Patentes:No hay patentes de este autor.